Award
Delivery Order #SPE2DR26FGJV9
Short-term Delivery Order for Xolair Autoinjectors to DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$10,484.64
Ceiling
$10,484.64
Awarded
March 16, 2026
Period of Performance
Mar 16, 2026 – Apr 06, 2026
Identifier
SPE2DR26FGJV9
NAICS
424210
This award is a delivery order contract issued under a broader indefinite delivery vehicle held by DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical products and services. The contract procures a specific pharmaceutical product, Xolair 300 MG/2 ML autoinjectors, intended to support the agency's healthcare needs. The contract is significant as it provides timely access to essential medications, thereby enhancing the agency's ability to respond to public health requirements. The scope of work includes the delivery of these specialized autoinjectors within a brief, defined period, demonstrating a focused procurement effort. The contract was awarded recently and is scheduled for completion within a few weeks. This delivery order is part of a larger long-term pharmaceutical supply agreement, ensuring consistent availability of critical pharmaceutical products. The award was conducted under the existing contract vehicle, implying a streamlined procurement process and likely competitive terms established in the base indefinite delivery vehicle.
Description
4571360619!XOLAIR 300 MG/2 ML AUTOINJECT 2ML